IS8351A - Lyfjaafurðir sem fela í sér bisfosfónöt - Google Patents

Lyfjaafurðir sem fela í sér bisfosfónöt

Info

Publication number
IS8351A
IS8351A IS8351A IS8351A IS8351A IS 8351 A IS8351 A IS 8351A IS 8351 A IS8351 A IS 8351A IS 8351 A IS8351 A IS 8351A IS 8351 A IS8351 A IS 8351A
Authority
IS
Iceland
Prior art keywords
products containing
pharmaceutical products
containing bisphosphonates
bisphosphonates
pharmaceutical
Prior art date
Application number
IS8351A
Other languages
English (en)
Inventor
Glausch Alexandra
Löffler Rolf
Sigg Juergen
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34312464&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IS8351(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of IS8351A publication Critical patent/IS8351A/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
IS8351A 2003-09-18 2006-03-13 Lyfjaafurðir sem fela í sér bisfosfónöt IS8351A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US50440203P 2003-09-18 2003-09-18
PCT/EP2004/010470 WO2005025551A2 (en) 2003-09-18 2004-09-17 Pharmaceutical products comprising bisphosphonates

Publications (1)

Publication Number Publication Date
IS8351A true IS8351A (is) 2006-03-13

Family

ID=34312464

Family Applications (1)

Application Number Title Priority Date Filing Date
IS8351A IS8351A (is) 2003-09-18 2006-03-13 Lyfjaafurðir sem fela í sér bisfosfónöt

Country Status (23)

Country Link
US (1) US7932241B2 (is)
EP (1) EP1663314A2 (is)
JP (1) JP4802096B2 (is)
KR (1) KR101015718B1 (is)
CN (1) CN1852739A (is)
AR (1) AR045670A1 (is)
AU (1) AU2004271731B2 (is)
BR (1) BRPI0414562A (is)
CA (1) CA2536206C (is)
CO (1) CO5680461A2 (is)
EC (1) ECSP066419A (is)
IL (1) IL173766A (is)
IS (1) IS8351A (is)
MA (1) MA28078A1 (is)
MY (1) MY141763A (is)
NO (1) NO20061682L (is)
NZ (1) NZ545343A (is)
PE (1) PE20050468A1 (is)
RU (1) RU2358739C2 (is)
TN (1) TNSN06084A1 (is)
TW (1) TWI345977B (is)
WO (1) WO2005025551A2 (is)
ZA (1) ZA200601209B (is)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050119230A1 (en) * 2003-09-18 2005-06-02 Alexandra Glausch Pharmaceutical products comprising bisphosphonated
MY141763A (en) 2003-09-18 2010-06-30 Novartis Ag Pharmaceutical products comprising bisphosphonates
EP2114368A1 (en) * 2006-11-17 2009-11-11 Besins Healthcare Pharmaceutical compositions comprising a bisphosphonate compound
EP1923049A1 (en) * 2006-11-17 2008-05-21 Besins Healthcare Pharmaceutical compositions comprising a bisphosphonate compound
SI3345607T1 (sl) * 2006-12-29 2023-03-31 Ossifi-Mab Llc Postopki spreminjanja rasti kosti z dajanjem antagonista ali agonista SOST ali WISE
JP5607408B2 (ja) * 2009-04-03 2014-10-15 帝人ファーマ株式会社 アレンドロン酸含有注射剤
US9169279B2 (en) 2009-07-31 2015-10-27 Thar Pharmaceuticals, Inc. Crystallization method and bioavailability
ES2650665T3 (es) 2009-07-31 2018-01-19 Grünenthal GmbH Método de cristalización y biodisponibilidad
US20160016982A1 (en) 2009-07-31 2016-01-21 Thar Pharmaceuticals, Inc. Crystallization method and bioavailability
US8882740B2 (en) * 2009-12-23 2014-11-11 Stryker Trauma Gmbh Method of delivering a biphosphonate and/or strontium ranelate below the surface of a bone
EP2363111A1 (en) 2010-03-01 2011-09-07 Combino Pharm, S.L. Stable pharmaceutical composition comprising bisphosphonate
WO2011132826A1 (en) * 2010-04-19 2011-10-27 Snu R&Db Foundation Transdermal drug delivery system and pharmaceutical composition for preventing or treating bone diseases
WO2012071517A2 (en) 2010-11-24 2012-05-31 Thar Pharmaceuticals, Inc. Novel crystalline forms
EP2712611A1 (en) 2012-09-27 2014-04-02 B. Braun Melsungen AG Stabilized aqueous compositions of neuromuscular blocking agents
RU2506085C1 (ru) * 2013-01-30 2014-02-10 Федеральное бюджетное учреждение науки "Государственный научный центр вирусологии и биотехнологии "Вектор" (ФБУН ГНЦ ВБ "Вектор") Тетраэтил-2-(2,2,6,6-тетраметилпиперидин-4-иламино)-этилен-1,1-бисфосфонат, обладающий противоопухолевой активностью
CN104721132B (zh) * 2013-12-21 2018-05-18 石药集团恩必普药业有限公司 一种唑来膦酸注射液及其制备方法
US10098813B2 (en) * 2014-09-03 2018-10-16 Sun Pharmaceutical Industries Limited Perfusion dosage form
GB201505347D0 (en) * 2015-03-27 2015-05-13 Salupont Consulting Ltd Sterilisation of s-nitrosothiols
CN108261393B (zh) * 2015-09-27 2020-10-27 山东则正医药技术有限公司 一种含有唑来膦酸的注射用药物组合物
WO2017208070A1 (en) 2016-05-31 2017-12-07 Grünenthal GmbH Bisphosphonic acid and coformers with lysin, glycin, nicotinamide for treating psoriatic arthritis
WO2019067145A1 (en) * 2017-08-28 2019-04-04 Asdera Llc USE OF CYCLODEXTRINS IN DISEASES AND DISORDERS INVOLVING PHOSPHOLIPID DISRUPTION
CA3076821A1 (en) * 2017-09-28 2019-04-04 Asdera Llc Use of cyclodextrins in diseases and disorders involving phospholipid dysregulation
CN110161168B (zh) * 2018-02-12 2022-12-20 四川科伦药物研究院有限公司 唑来膦酸及其杂质的高效液相色谱检测方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0275821B1 (de) * 1986-11-21 1992-02-26 Ciba-Geigy Ag Neue substituierte Alkandiphosphonsäuren
JP3672342B2 (ja) * 1994-09-26 2005-07-20 アステラス製薬株式会社 ビスホスホン酸又はその誘導体を含有する注射液とその安定化方法、及び注射液アンプル
GB0012209D0 (en) * 2000-05-19 2000-07-12 Novartis Ag Organic compounds
WO2002022136A1 (en) 2000-09-18 2002-03-21 F H Faulding & Co Limited Diphosphonate solutions
CZ20032951A3 (cs) 2001-05-02 2004-02-18 Sicor Inc. Injikovatelný pamidronate disodium
CA2372450A1 (en) 2001-05-10 2001-09-19 Pharmaceutical Partners Of Canada Inc. Liquid injectable formulation of disodium pamidronate
MY141763A (en) 2003-09-18 2010-06-30 Novartis Ag Pharmaceutical products comprising bisphosphonates

Also Published As

Publication number Publication date
IL173766A (en) 2012-10-31
CA2536206A1 (en) 2005-03-24
TWI345977B (en) 2011-08-01
KR101015718B1 (ko) 2011-02-22
TNSN06084A1 (en) 2007-10-03
US7932241B2 (en) 2011-04-26
JP2007505861A (ja) 2007-03-15
NO20061682L (no) 2006-06-14
MA28078A1 (fr) 2006-08-01
AU2004271731A1 (en) 2005-03-24
AU2004271731B2 (en) 2008-07-24
PE20050468A1 (es) 2005-10-03
CA2536206C (en) 2010-08-24
MY141763A (en) 2010-06-30
CN1852739A (zh) 2006-10-25
AR045670A1 (es) 2005-11-02
RU2358739C2 (ru) 2009-06-20
TW200522969A (en) 2005-07-16
RU2006112596A (ru) 2007-11-10
US20070015736A1 (en) 2007-01-18
WO2005025551A2 (en) 2005-03-24
IL173766A0 (en) 2006-07-05
ZA200601209B (en) 2007-04-25
CO5680461A2 (es) 2006-09-29
BRPI0414562A (pt) 2006-11-07
JP4802096B2 (ja) 2011-10-26
KR20060087568A (ko) 2006-08-02
ECSP066419A (es) 2006-09-18
NZ545343A (en) 2010-08-27
WO2005025551A3 (en) 2006-01-12
EP1663314A2 (en) 2006-06-07

Similar Documents

Publication Publication Date Title
IS8351A (is) Lyfjaafurðir sem fela í sér bisfosfónöt
EG27104A (en) Pharmaceutical compounds
GB0315657D0 (en) Pharmaceutical compounds
IS8460A (is) Lyfjafræðileg samsetning sem inniheldur kvetíapín
IS2946B (is) Lyfjablanda sem felur í sér andrógen
GB0327723D0 (en) Pharmaceutical compositions
GB0218625D0 (en) Pharmaceutical compounds
ZA200605080B (en) Pharmaceutical compositions
GB0308511D0 (en) Pharmaceutical compounds
GB0300531D0 (en) Pharmaceutical compositions
HK1084670A1 (en) Pharmaceutical compositions comprising cabbinochreme type compounds
GB0215775D0 (en) Pharmaceutical compounds
EP1648411A4 (en) PHARMACEUTICAL COMPOSITIONS
IS7458A (is) Stöðug lyfjablanda sem inniheldur þátt VIII
AU307054S (en) Pharmaceutical packaging
GB0316206D0 (en) Pharmaceutical formulation
GB0317315D0 (en) Pharmaceutical compounds
GB0313766D0 (en) Pharmaceutical compounds
GB0301736D0 (en) Pharmaceutical compounds
NO20034952D0 (no) Farmasöytiske forbindelser
GB0305579D0 (en) Pharmaceutical compositions
ZA200509741B (en) Pharmaceutical composition comprising cyclic smatostin analogues
GB0328040D0 (en) Pharmaceutical uses of bisphosphonates
GB0329617D0 (en) Pharmaceutical compounds
GB0310361D0 (en) Pharmaceutical compound